Shield-1

 CAS No.: 914805-33-7  Cat No.: BP-300188  Purity: >98% 4.5  

Shield-1 is a synthetic ligand for destabilizing domain systems based on engineered FKBP-derived protein tags. It binds the destabilizing domain and stabilizes tagged fusion proteins, making it an important chemical biology tool for conditional protein control. Shield-1 is not a conventional PROTAC target warhead, but it is highly relevant to protein stability and degradation research because it enables ligand-regulated protection of engineered proteins from cellular degradation. In experimental workflows, Shield-1 can be used to control protein abundance, validate degrader phenotypes, study reversible protein stabilization, and compare induced stabilization with induced degradation systems. Its value lies in temporal control of tagged protein expression, target validation, protein homeostasis studies, engineered cellular models, and chemical-genetic approaches for dissecting protein function in living systems.

Shield-1

Structure of 914805-33-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
Ligand for Target Protein
Molecular Formula
C42H56N2O10
Molecular Weight
748.9
Appearance
Solid Powder

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Purity
>98%
Appearance
Solid Powder
Storage
Store at -20°C
IUPACName
[(1R)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carboxylate
Synonyms
AquaShield-1
InChI Key
NMFHJNAPXOMSRX-PUPDPRJKSA-N
InChI
InChI=1S/C42H56N2O10/c1-7-33(31-27-38(49-4)40(51-6)39(28-31)50-5)41(45)44-18-9-8-13-34(44)42(46)54-35(16-14-29-15-17-36(47-2)37(25-29)48-3)30-11-10-12-32(26-30)53-24-21-43-19-22-52-23-20-43/h10-12,15,17,25-28,33-35H,7-9,13-14,16,18-24H2,1-6H3/t33-,34-,35+/m0/s1
SMILES
CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCCN5CCOCC5
Mechanism

Target: This ligand targets engineered FKBP12(F36V) destabilizing domains in biochemical or cellular target-engagement studies.

Mechanism of Action: Shield-1 is best established as a ligand for engineered FKBP12(F36V) destabilizing domains rather than a conventional endogenous PROTAC target ligand. In degrader-related experimental design, this binding interaction can be exploited to control stability of fusion proteins or to build chemically induced proximity systems when connected to an appropriate linker and recruitment module. If adapted into a bifunctional degrader architecture, the ligand portion would recognize the engineered FKBP12 tag while the second ligand recruits an E3 ligase, enabling proximity-dependent ubiquitination and proteasomal degradation of the tagged protein.

Applications

• PROTAC E3 Recruitment Tool: Shield-1 can be used in PROTAC research as a chemically controllable component to modulate recruitment of an E3 ligase system. By enabling tunable formation of ternary complexes, Shield-1 supports studies of how ligase engagement kinetics and affinity influence ubiquitination efficiency and subsequent target protein degradation.

• Inducible Degradation Control: Shield-1–dependent PROTAC designs facilitate on-demand targeted protein degradation, allowing researchers to vary degrader activity over time. This enables mechanistic experiments to quantify degradation onset, dose–response relationships, and recovery after washout, supporting rigorous mapping of degradation dynamics in cellular systems.

• Ternary Complex Optimization: In PROTAC development workflows, Shield-1–enabled ligase recruitment can help dissect ternary complex stability requirements. Researchers can systematically compare degradation potency under different induction conditions, informing structure–activity relationships that govern productive ubiquitination and reducing off-target proteolysis.

• Mechanistic Ubiquitination Studies: Shield-1–driven PROTAC platforms are suitable for probing ubiquitin pathway engagement. By controlling when the degrader becomes active, experiments can measure ubiquitination intermediates, dependence on specific E2/E3 factors, and the contribution of proteasomal processing to overall target turnover.

• Target Pathway Perturbation: Shield-1–controlled PROTAC activity supports targeted perturbation of signaling networks by selectively degrading chosen proteins. This approach is valuable for testing causal roles of protein abundance, examining downstream transcriptional or phenotypic effects, and distinguishing degradation-dependent mechanisms from occupancy-only binding.

1. Tunable Protein Stabilization In Vivo Mediated by Shield-1 in Transgenic Medaka
Alexander Froschauer, Lisa Kube, Alexandra Kegler, Christiane Rieger, Herwig O Gutzeit PLoS One. 2015 Jul 6;10(7):e0131252.doi: 10.1371/journal.pone.0131252.eCollection 2015.
Techniques for conditional gene or protein expression are important tools in developmental biology and in the analysis of physiology and disease. On the protein level, the tunable and reversible expression of proteins can be achieved by the fusion of the protein of interest to a destabilizing domain (DD). In the absence of its specific ligand (Shield-1), the protein is degraded by the proteasome. The DD-Shield system has proven to be an excellent tool to regulate the expression of proteins of interests in mammalian systems but has not been applied in teleosts like the medaka. We present the application of the DD-Shield technique in transgenic medaka and show the ubiquitous conditional expression throughout life. Shield-1 administration to the water leads to concentration-dependent induction of a YFP reporter gene in various organs and in spermatogonia at the cellular level.
2. Design and Combinatorial Development of Shield-1 Peptide Mimetics Binding to Destabilized FKBP12
Daniel Madsen, Frederik P Jørgensen, Daniel Palmer, Milena E Roux, Jakob V Olsen, Mikael Bols, Sanne Schoffelen, Frederik Diness, Morten Meldal ACS Comb Sci. 2020 Mar 9;22(3):156-164.doi: 10.1021/acscombsci.9b00197.Epub 2020 Feb 23.
On the basis of computational design, a focused one-bead one-compound library has been prepared on microparticle-encoded PEGA1900 beads consisting of small tripeptides with a triazole-capped N-terminal. The library was screened towards a double point-mutated version of the human FKBP12 protein, known as the destabilizing domain (DD). Inspired by the decoded library hits, unnatural peptide structures were screened in a novel on-bead assay, which was useful for a rapid structure evaluation prior to off-bead resynthesis. Subsequently, a series of 19 compounds were prepared and tested using a competitive fluorescence polarization assay, which led to the discovery of peptide ligands with low micromolar binding affinity towards the DD. The methodology represents a rapid approach for identification of a novel structure scaffold, where the screening and initial structure refinement was accomplished using small quantities of library building blocks.
3. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules
Laura A Banaszynski, Ling-Chun Chen, Lystranne A Maynard-Smith, A G Lisa Ooi, Thomas J Wandless Cell. 2006 Sep 8;126(5):995-1004.doi: 10.1016/j.cell.2006.07.025.
Rapid and reversible methods for perturbing the function of specific proteins are desirable tools for probing complex biological systems. We have developed a general technique to regulate the stability of specific proteins in mammalian cells using cell-permeable, synthetic molecules. We engineered mutants of the human FKBP12 protein that are rapidly and constitutively degraded when expressed in mammalian cells, and this instability is conferred to other proteins fused to these destabilizing domains. Addition of a synthetic ligand that binds to the destabilizing domains shields them from degradation, allowing fused proteins to perform their cellular functions. Genetic fusion of the destabilizing domain to a gene of interest ensures specificity, and the attendant small-molecule control confers speed, reversibility, and dose-dependence to this method. This general strategy for regulating protein stability should enable conditional perturbation of specific proteins with unprecedented control in a variety of experimental settings.

Shield-1 is a FKBP-family ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of Shield-1 is characterized by carboxylic acid or carboxylate handle; primary or secondary amine/basic nitrogen centers; macrocyclic or peptidomimetic scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The acid handle supports amide coupling with amino-PEG, alkyl-diamine, piperazine, or aminoalkyl E3-ligase ligands. For FKBP-directed chemical biology, it may be connected to degradation or dimerization modules through flexible PEG/alkyl or amide-containing linkers, subject to FKBP-binding SAR. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
Germany
Inquiry Basket